E Longeval
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 11
- Lung Cancer Research Studies 6
- Cancer Treatment and Pharmacology 4
-
- Neuroendocrine Tumor Research Advances 5
- Co-authors
- Jean Klášterský (6 shared papers)Guy Leclercq (2 shared papers)Jean-Claude Heuson (1 shared paper)Richard Sylvester (1 shared paper)W Mattheiem (1 shared paper)Claude Nicaise (2 shared papers)Pierre Stryckmans (1 shared paper)Nicole Legros (1 shared paper)
- Journals
- Cancer (4 papers)Acta Oncologica (1 paper)Acta Neurochirurgica (1 paper)Cancer Treatment Reviews (1 paper)Journal of Endocrinology (1 paper)
- Partner nations
- BelgiumSwitzerlandFrance
In The Last Decade
E Longeval
16 papers receiving 426 citations
Peers
Comparison fields: 5 of 61
- Oncology 296
- Pulmonary and Respiratory Medicine 145
- Genetics 134
- Cancer Research 63
- Epidemiology 109
Countries citing papers authored by E Longeval
This map shows the geographic impact of E Longeval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Longeval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Longeval more than expected).
Fields of papers citing papers by E Longeval
This network shows the impact of papers produced by E Longeval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Longeval. The network helps show where E Longeval may publish in the future.
Co-authors
The 25 scholars most cited alongside E Longeval, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1977 | 117 | |
| 2 | 1982 | 97 | |
| 3 | High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium). | 1980 | 70 |
| 4 | 1982 | 61 | |
| 5 | Estrogen and progesterone receptors in human breast cancer. | 1977 | 47 |
| 6 | 1982 | 18 | |
| 7 | 1985 | 17 | |
| 8 | 1975 | 15 | |
| 9 | 1977 | 14 | |
| 10 | 1988 | 10 | |
| 11 | Peritoneoscopy as a diagnostic supplement to liver function tests and liver scan in patients with carcinoma. | 1977 | 10 |
| 12 | Improvement of hematological and general tolerance to CMF by high-dose medroxyprogesterone acetate (HD-MPA) adjuvant treatment for primary node positive breast cancer (analysis of 100 patients). | 1987 | 7 |
| 13 | 1989 | 6 | |
| 14 | [Leukemoid reaction and hypercalcemia in carcinoma of the bladder]. | 1990 | 3 |
| 15 | 1981 | 3 | |
| 16 | Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemia. | 1976 | 3 |
| 17 | [Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results]. | 1986 | 1 |
About E Longeval
E Longeval is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Genetics and Public Health, Environmental and Occupational Health, having authored 17 papers that have together received 499 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (6 papers), Estrogen and related hormone effects (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gestational Trophoblastic Disease Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (1 paper) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Oncology (296 citations), Pulmonary and Respiratory Medicine (145 citations), Genetics (134 citations), Cancer Research (63 citations) and Epidemiology (109 citations). E Longeval has collaborated with scholars based in Belgium, Switzerland and France. Frequent co-authors include Jean Klášterský, Guy Leclercq, Jean-Claude Heuson, Richard Sylvester, W Mattheiem, Claude Nicaise, Pierre Stryckmans, Nicole Legros, Danièle Weerts and Jerzy Hildebrand. Their work appears in journals such as Cancer, Acta Oncologica, Acta Neurochirurgica, Cancer Treatment Reviews and Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.